SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-23-015188
Filing Date
2023-05-02
Accepted
2023-05-02 16:30:41
Documents
14
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm   iXBRL 10-K/A 227936
2 ex31-1.htm EX-31.1 3927
3 ex31-2.htm EX-31.2 3952
  Complete submission text file 0001493152-23-015188.txt   468183

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT atrx-20221231.xsd EX-101.SCH 3236
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT atrx-20221231_lab.xml EX-101.LAB 36257
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT atrx-20221231_pre.xml EX-101.PRE 23752
8 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 5943
Mailing Address P.O. BOX 2161 WAKE FOREST NC 27588
Business Address P.O. BOX 2161 WAKE FOREST NC 27588 919-578-5901
Adhera Therapeutics, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-13789 | Film No.: 23879603
SIC: 2834 Pharmaceutical Preparations